跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CSL Bulk Influenza Vaccine (Split virion inactivated). - TGA Drug Approval Details
Approvals
/
TGA
/
CSL Bulk Influenza Vaccine (Split virion inactivated).
Approved
STANDARD
CSL Bulk Influenza Vaccine (Split virion inactivated).
Seqirus Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
a5f9f4bc095b1b0f
Company
Seqirus Pty Ltd
Type
Standard
Approval Details
Approval Id
a5f9f4bc095b1b0f
Product Name
CSL Bulk Influenza Vaccine (Split virion inactivated).
Artg Id
106754
Artg Name
CSL Bulk Influenza Vaccine (Split virion inactivated).
Sponsor
Seqirus Pty Ltd
Company Detail Path
/organization/seqirus-pty-ltd
Artg Date
2004-08-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
a5f9f4bc095b1b0f
Type
Standard
Back to TGA Approvals
